文献速递烧伤创面修复

阿尔及利亚烧伤患者铜绿假单胞菌耐药特征分析

Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.
PubMed 文献 · Burns · 2021-03-17

该研究分析了2016年4月至2019年10月阿尔及利亚军事医院烧伤科47株非重复铜绿假单胞菌的耐药表型与基因型。结果显示59.57%为ESBL表型阳性,100%为MBL表型阳性,未检出blaNDM-1、blaIMP、blaVIM基因,首次在阿尔及利亚报道blaCTX-M2阳性菌株。

要点

  • 47株烧伤患者铜绿假单胞菌中59.57%为ESBL表型阳性、100%为MBL表型阳性。
  • 28株ESBL产菌中23株(82.14%)blaCTX-M2阳性,18株(38.29%)blaPER阳性,16株(34.04%)blaTEM阳性。
  • 所有MBL表型阳性菌株均未检出blaNDM-1、blaIMP、blaVIM基因。

核心结论

  • 首次在阿尔及利亚检出blaCTX-M2阳性和blaPER阳性的铜绿假单胞菌临床分离株。
  • 提示多重耐药菌株已传播至北非地区。
  • 明确耐药基因型有助于选择烧伤患者铜绿假单胞菌感染的有效抗菌策略。

研究设计与样本

  • 2016年4月至2019年10月在阿尔及利亚军事医院烧伤科收集47株非重复铜绿假单胞菌。
  • 采用琼脂扩散法和Phoenix自动化系统进行药敏试验。
  • PCR鉴定耐药基因,ERIC-PCR进行分子分型。

主要发现

  • 47株多重耐药铜绿假单胞菌中59.57%表型为ESBL阳性,100%表型为MBL阳性。
  • 28株ESBL产菌中23株(82.14%)blaCTX-M2阳性,18株(38.29%)blaPER阳性,16株(34.04%)blaTEM阳性。
  • 5株(17.9%)同时携带blaCTX-M2、blaTEM和blaPER基因。
  • 所有ESBL阳性菌株均未检出blaSHV、blaVEB、blaGES基因。
  • 45株(95.74%)oprD基因阳性,blaCTX-M2阳性菌株经ERIC-PCR分为11个克隆。

关键数值与推荐

  • ESBL表型阳性率59.57%(28/47),MBL表型阳性率100%(47/47)。
  • blaCTX-M2阳性23/28(82.14%),blaPER阳性18/47(38.29%),blaTEM阳性16/47(34.04%)。
  • blaCTX-M2、blaTEM、blaPER共携带5/28(17.9%)。
  • oprD基因阳性45/47(95.74%)。

临床怎么用

  • 对烧伤患者铜绿假单胞菌感染应结合耐药基因型检测指导抗菌药物选择。
  • 在阿尔及利亚及类似地区需警惕产ESBL和MBL多重耐药铜绿假单胞菌的流行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence of multidrug-resistant (MDR) Pseudomonas aeruginosa (PA) producing extended-spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs) in burn patients in Algeria. METHODS: Between April 2016 and October 2019, 47 non-redundant isolates of PA were collected from 47 burn patients admitted to the Department of Burns at the Military Hospital of Algiers in Algeria. Antibiotic susceptibility testing was performed by agar diffusion and the Phoenix automated method. Resistance genes were identified by PCR, and molecular typing of isolates was carried out by enterobacterial repetitive intergenic consensus (ERIC) sequences-polymerase chain reaction (PCR). RESULTS: Among the 47 non-redundant MDR PA strains isolated, 59.57% were phenotypically ESBLs-positive, and 100% were phenotypically MBL-positive. The ESBL-positive isolates were subsequently screened for six groups of bla genes encoding ESBL-type enzymes, namely blaCTX-M2, blaPER, blaTEM, blaSHV, blaVEB, and blaGES. Out of the 28 ESBL-producing strains, 23 (82.14%) were blaCTX-M2 positive; 18 (38.29%) were blaPER positive, and 16 (34.04%) were blaTEM positive, while 5 (17.9%) were co-harboring blaCTX-M2, blaTEM, and blaPER genes. The blaSHV, blaVEB, and blaGES genes were not detected in any of the ESBL positive isolates. Since all isolates were MBL-positive, all 47 strains were screened for the blaNDM-1, blaIMP, blaVIM genes that produce MBLs; however, none of these genes were detected. Additional screening for the oprD gene demonstrated that 45 (95.74%) of the isolates were positive for this gene. Finally, ERIC PCR revealed 11 distinct PA clones among the blaCTX-M2 positive strains. CONCLUSION: This is the first study to report the presence of CTX-M2-producing PA in the North Africa region and the first to detect blaCTX-M2-positive and blaPER-positive PA clinical isolates in Algeria, therefore demonstrating the spread of such MDR strains to this part of the world. Identification of bacterial genotypic alterations that confer antibiotic resistance is critical in determining the most effective antimicrobial strategies to be employed. Therefore, our findings could potentially facilitate clinical decision making regarding the antibiotics of choice for the treatment of burn patients that suffer from PA infections in Algeria.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Tchakal-Mesbahi A, Metref M, Singh VK, et al. Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients. Burns. 2021. PMID: 33795157. doi:10.1016/j.burns.2021.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。